Sisters Reach Settlement in High Court Over Late Cervical Cancer Diagnosis
The sisters of Mary Walsh, who lost their sibling to cervical cancer a decade ago, have formally settled a High Court action against the Health Service Executive (HSE). This resolution brings closure to a long-standing dispute concerning the alleged failings in the interpretation and reporting of Mary’s initial cervical smear test.
Mary Walsh’s Journey with Cervical Cancer
Mary Walsh, a 39-year-old accounting technician from Waterford city, succumbed to cervical cancer on December 11, 2015. Her death came several months after her diagnosis of Stage 4 cervical cancer, highlighting the significant toll of late diagnosis in cancer management.
The Legal Battle
Mary’s sisters, Patricia Carey from Kilmeaden, and Julie Keyes from Tramore, took legal action against the HSE. They alleged that there was a failure to correctly interpret or report the results of Mary’s smear sample taken in November 2008. The sisters also claimed that the HSE did not diagnose or report the sample as abnormal, which they believed could have led to an earlier diagnosis.
Key Claims and Medical Timeline
Mary initially underwent a cervical smear test as part of the national screening programme in November 2008. The results indicated a negative diagnosis, and she was advised to repeat the test in three years. However, in June 2013, her follow-up smear was marked as inadequate, requiring another test in three months.
April 2014 saw another smear test, which was again reported negative, with a recommendation for a follow-up in three years. A subsequent HSE review of Mary’s smear samples confirmed the initial findings from 2013 and 2014. Crucially, this review did not examine the sample taken in 2008, raising questions about the thoroughness of the screening process.
Allegations of Medical Negligence
The sisters contended that the failure to properly care for their sister and diagnose her condition early allowed the cervical cancer to spread undetected. They further alleged that the HSE did not exercise reasonable skill, care, and judgment in reviewing Mary’s initial smear sample. Additionally, they argued that the lack of clear communication about the outcomes of the smear sample reviews contributed to the delayed diagnosis.
The Court’s Judgment and Settlement Terms
The legal proceedings, presented by Jeremy Maher SC of Cian O’Carroll solicitors, emphasized the missed opportunity for timely and effective management of Mary’s condition. The terms of the settlement remained confidential, with the primary focus on the allocation of the €35,000 statutory mental distress payment made to the sisters. Mr. Justice Paul Coffey expressed his deepest sympathy for the Walsh family, recognizing the tragedy of their loss.
Impact on Cervical Cancer Screening
This settlement underscores the critical importance of accurate and timely cervical cancer screening. The missed diagnoses in Mary Walsh’s case highlight the need for a robust and meticulous review process of all smear samples, ensuring that no individual is left without essential care due to administrative oversights.
Conclusion
While the settlement offers a measure of closure for the Walsh sisters, it also serves as a reminder of the importance of vigilant medical practices and transparent communication between healthcare providers and patients. This case highlights the potential consequences of even minor oversights in a screening program with the potential to save lives.
Do you have a personal story related to a medical condition or a health concern that you believe merits further discussion? Share your thoughts in the comments below or follow us on social media for more insights and updates. Your experiences can help others and foster important conversations. Subscribe to our newsletter to receive the latest health news directly in your inbox.
